Solution stability of linear vs. cyclic RGD peptides

Journal of Peptide Research

Volumn 53, Issue 5, 1999, Pages 530-541

  Bogdanowich Knipp, S J ^a   Chakrabarti, S ^a   Williams, T D ^a   Dillman, R K ^b   Siahaan, Teruna J ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b SANOFI   (France)

Author keywords

Conformational rigidity; Cyclic imide; Degradation; Disulphide bond; Iso peptide; RGD peptide; Solution stability

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID;

ARTICLE; CONFORMATIONAL TRANSITION; MOLECULAR STABILITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN STABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STRUCTURE ANALYSIS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; HYDROGEN-ION CONCENTRATION; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; OLIGOPEPTIDES; PENICILLAMINE; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; PROTEIN DENATURATION; SOLUBILITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033029777     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.1999.00052.x     Document Type: Article

References (33)

1. Hynes, R.O. (1987) Integrins: a family of cell surface receptors. Cell 48, 549-554.
2. Ku, T.W., Ali, F.A., Barton, L.S., Bean, J.W., Bondinell, W.E., Burgess, J.L., Callahan, J.F.R.R., Calvo, L., Chen, Eggleston, D.S., Gleason, J.G., Huffman, W.F., Hwang, S.M., Jakas, D.R., Karash, C.B., Keena, R.M., Kopple, K.D., Miller, W.H., Newlander, K.A., Nichols, A., Parker, M.F., Uzinskas, I. &Venslavsky, J.W. (1993) Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptide. J. Am. Chem. Soc. 115, 8861-8862.
3. Ojima, I., Chakravarty, S. & Dong, Q. (1995) Antithrombic agents: from RGD to peptide mimetics. Bioorganic. Med. Chem. 3, 337-360.
4. Samanen, J., Ali, F., Romoff, T., Calvo, R., Sorenson, E., Vasko, J., Storer, B., Berry, D., Bennett, D., Strohsacker, M., Powers, D., Stadel, J. & Nichols, A. (1991) Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. J. Med. Chem. 34, 3114-3125.
5. Jois, S.D.S., Tambunan, U.S.F., Chakrabarti, S. & Siahaan, T.J. (1996) Solution structure of a cyclic peptide that inhibits platelet aggregation. J. Biomol. Struc. Dyn. 14, 1-11.
6. Clarke, S. (1987) Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. Int. J. Peptide Protein Res. 30, 808-821.
7. Geiger, T. & Clarke, S. (1987) Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. J. Biol. Chem. 262, 785-794.
8. Manning, M.C., Patel, K. & Borchardt, R.T. (1989) Stability of protein pharmaceuticals. Pharm. Res. 6, 903-918.
9. Hruby, V.J. (1982) Conformational restrictions of biologically active peptides via amino acid side chain groups. Life Sci. 31, 189-199.
10. Cody, W.L., Mahoney, M., Knittel, J.J., Hruby, V.J., Castrucci, A.M. & Hadley, M.E. (1985) Cyclic melanotropins. 9. 7-D-Phenylalanine analogues of the active-site sequence. J. Med. Chem. 28, 583-588.
11. Hruby, V.J. (1989) Designing molecules: specific peptides for specific receptors. Epilepsia 30, S42-S50.
12. Hadley, M.E., Marwan, M.M., al-Obeidi, F., Hruby, V.J. & Castrucci, A.M. (1989) Linear and cyclic alpha-melanotropin[4-10]-fragment analogues that exhibit superpotency and residual activity. Pigment Cell Res. 2, 478-484.
13. Cleland, W.W. (1964) Dithiothreitol, a new protective reagent for SH groups. Biochemistry 3, 480.
14. Bax, A. & Davis, G.D. (1985) Mlev-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65, 355-360.
15. Bax, A. & Davis, D.G. (1985) Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 63, 207-213.
16. Patel, K. & Borchardt, R.T. (1990) Chemical pathways for peptide degradation: II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide. Pharm. Res. 7, 703-711.
17. Oliyai, C. & Borchardt, R.T. (1993) Chemical pathways for peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide. Pharm. Res. 10, 95-102.
18. Patel, K. & Borchardt, R.T. (1990) Chemical pathways for peptide degradation: III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides. Pharm. Res. 7, 787-793.
19. Oliyai, C. & Borchardt, R.T. (1994) Chemical pathways of degradation. VI. Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides. Pharm. Res. 11, 751-758.
20. Stephenson, R.C. & Clarke, S. (1989) Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J. Biol. Chem. 264, 6164-6170.
21. Clarke, S., Stephenson, R.C. & Lowenson, J.D. (1992) Lability of asparagine and aspartic acid residues in proteins and peptides. In: Stability of Protein Pharmaceuticals, Part A: Chemical and Physical Pathways of Protein Degradation (Ahern, T.J. & Manning, M.C., eds). Plenum Press, New York, pp. 1-29.
22. Bogdanowich-Knipp, S., Jois, D.S.S. & Siahaan, T.J. (1999) The effect of conformation on the solution stability of linear vs. cyclic RGD peptides. J. Peptide Res. 53, 523-529.
23. Gaines, S.M. & Rada, J.L. (1986) Aspartame decomposition and epimerization in the diketopiperazine and dipeptide products as a function of pH and temperature. J. Org. Chem. 53, 2757-2764.
24. Skwierczynski, R.D. & Connors, K.A. (1994) Solvent effects on chemical processes. 8. Demethylation kinetics of aspartame in binary aqueou-organic solvents. J. Pharm. Sci. 83, 1690-1696.
25. Furda, I., Malizia, P.M., Koler, M.G. &Vernieri, P.J. (1975) Decomposition products of L-aspartyl-L-phenylalanine methyl ester and their identification by gas-liquid chromatography. J. Agr. Food Chem. 23, 340-343.
26. Skwiercynski, R.D. & Connors, K.A. (1993) Demethylation kinetics of aspartame and L-phenylalanine methyl ester in aqueous solution. Pharm. Res. 10, 1174-1180.
27. Falick, A.M. & Maltby, D.A. (1989) Derivatization of hydrophilic peptides for liquid secondary ion mass spectrometry at the picomole level. Anal. Biochem. 182, 165-169.
28. Connors, K.A., Amidon, G.L. & Stella, V.J. (1986) Chemical Stability of Pharmaceuticals, pp. 90-91, Wiley-Interscience, New York.
29. Gursoy, R.N. & Siahaan, T.J. (1996) Chemical stability of the disulphide bond in a model pentapeptide, cyclo(1,4) Cys-Gly-Phe-Cys-Gly-OH. Pharm. Res. 13, S-101.
30. Torchinsky, Y.M. (1981) Sulfur in Proteins, pp. 82-90, Plenum Press, New York.
31. Florence, T.M. (1980) Degradation of protein disulphide bonds in dilute alkali. Biochem. J. 189, 507-520.
32. Whitaker, J.R. & Feency, R.E. (1983) Chemical and physical modification of proteins by the hydroxide ion. CRC Crit. Rev. Food Sci. Nutr. 19, 173-212.
33. 2. Int. J. Pept. Prot. Res. 44, 427-434.